Mekorot 2025: Regulation Cracked the Capital Base, but the Water System Still Runs

Understanding the company

Mekorot is not just another infrastructure company. It is the central operating machine of Israel's water system, producing, collecting, treating, transporting and supplying water at a national scale, with about 4,500 water facilities and roughly 11,000 km of active pipelines. It is also a listed issuer with bonds only, not equity. That means the right way to read 2025 is not "what happens to the stock," but what happens to the credit layer, the rating, access to debt markets and the company's ability to keep executing a multi-billion-shekel development plan.

What is still working now is the operating system itself. Mekorot supplied about 1,898.6 mcm of water in 2025, up 1.6% from 2024, and according to the company completed about NIS 1.5 billion of development-plan execution even under a complex security environment. Base demand remains firm, the company's national role has not changed, and the bond market was still open in December 2025 with a NIS 1.5 billion gross issuance in Series 11.

What is no longer clean is the economics above that machine. The new Water Authority rules took effect on January 1, 2026, changed the way return on assets is recognized, moved more of the framework to normative recognition, set an 8% FFO-to-debt target in regulatory terms, and cut the company's equity through a NIS 1.367 billion impairment. The active bottleneck today is therefore not water demand and not operations. It is whether the regulatory model still knows how to fund and reward an infrastructure company that has to keep building.

That matters now because a superficial reader could stop at the impairment and think the issue is mainly a one-off accounting clean-up. That is the wrong read. Even before the write-down, 2025 had already shown a real deterioration in the economics of the core business: revenue rose 7.7% to NIS 5.772 billion, but cost of sales and works rose 15.7% to NIS 5.584 billion, and gross profit fell 64.6% to just NIS 188 million. In other words, the story starts with a widening gap between actual costs and recognized coverage, and only then turns into an accounting impairment story.

Mekorot's quick orientation map looks like this:

There is also a deeper shift in the structure of water sources. Mekorot says that as of the report date it self-produces about 61% of the water it supplies, while the rest comes from third parties. Purchased desalinated water jumped to 680.6 mcm in 2025 from 541.2 mcm in 2024, and the cost of buying water from others rose to NIS 2.396 billion from NIS 1.777 billion. In plain terms, the national system is relying more and more on purchased desalinated water, which raises dependence on a regulatory framework that can cover returns, not only pipes.

Events and triggers

The water-rule amendment is an economic event, not just a legal one

The core trigger in this story is the water-rule amendment published on December 31, 2025 and effective from January 1, 2026. This is not a narrow technical item. It directly affects return recognition on assets, introduces a new normative margin, moves development-project recognition to a normative price list, changes the way revenue is recognized so that 50% of pre-tax profit is included in recognized income, and sets an 8% FFO-to-debt target in regulatory terms.

From the Water Authority's point of view, the positive side is the claim that the new rules actually add roughly NIS 40 million of annual tariff recognition, increase recognition of energy, municipal-tax, maintenance, cyber and wage costs, and can hold FFO-to-debt at no less than 8%. From Mekorot's point of view, the negative side is that the new model does not cover full actual costs, lowers the return on existing assets, and shifts much more normative risk onto development projects.

The point that matters is that this dispute is no longer theoretical. It has already moved into the financial statements. Mekorot recorded a NIS 1.367 billion impairment on fixed assets and another NIS 9 million on intangible assets. The recoverable amount of the company's assets was set at NIS 18.612 billion versus NIS 19.979 billion before the test. In plain English, equity has already absorbed the company's interpretation of the new regulatory framework.

The High Court petition says the fight is still open

On March 29, 2026, one day before the financial statements were approved, Mekorot filed an urgent petition with Israel's High Court against the Water Authority, the Ministry of Energy, the government, the financial-resilience committee and the Government Companies Authority. The company is asking for the financial-resilience committee to be convened urgently and for the amended rules to be reconsidered. Its argument is straightforward: the new framework harms profitability, financial resilience, the credit rating and the ability to finance the national development plan.

This matters because it moves the dispute from a professional regulatory arena into a legal and policy arena. But the ball still needs to be put in the right place: the petition does not erase the damage already recorded in 2025. It only defines the arena that will determine whether 2026 becomes a stabilization year or a further deterioration year.

The December 2025 bond issue bought time, but did not settle the argument

On December 11, 2025, Mekorot completed an expansion of Series 11 in a nominal amount of NIS 1.364 billion, with net proceeds of about NIS 1.482 billion and an effective interest rate of roughly 2.8%. This matters for two reasons. First, it proves that access to the debt market was still open just before the new rules took effect. Second, it bought the company time to move through 2026 without falling immediately into a liquidity corner.

But it is just as important to see what that issuance does not prove. It was completed before the impairment was booked in the financial statements and before the court petition was filed. So it says something about market confidence in the structure before the regulatory reset, not necessarily about Mekorot's ability to refinance the same scale of debt after the equity hit has already been recognized.

Electricity can offer partial relief, but it does not solve the core issue

In October 2023 the company received a license to supply electricity without generation assets, and in January 2026 it won an Electricity Authority tender that allows it to buy power from the system manager at a uniform tariff below its current average tariff, at a scale of up to 25 megawatts, through 2029. The annual cost of electricity purchased under that agreement is about NIS 100 million.

This is a positive trigger because pumping-energy expense had already reached NIS 1.004 billion in 2025. But the scale needs to stay in proportion: even if the electricity benefit is fully realized, it improves one cost line. It does not resolve the question of return on capital, the normative price list or the coverage of development spending.

The development subsidiary has broadened, but it still does not change the thesis

A government decision from October 2025 expanded the development arm's activity in wastewater-treatment management and maintenance, and also regularized the Cyprus holding-company structure. That sounds strategic, and rightly so. But the numbers still matter: in 2025 the development segment contributed NIS 21 million of revenue and NIS 15 million of segment result, versus NIS 6.019 billion of revenue and NIS 785 million of segment result in water supply.

In other words, diversification exists, but it is still a side layer. It cannot on its own offset regulatory pressure in the core water business.

Efficiency, profitability and competition

The deterioration started in the core business, not in the impairment

Revenue rose to NIS 5.772 billion, but costs rose faster. That is the central fact of 2025. Cost of sales and works climbed to NIS 5.584 billion, so gross profit fell to just NIS 188 million. This is not mainly an accounting headline. It is a basic economics problem.

A closer look at the cost build-up makes that clear. The cost of buying water from others rose 34.8% to NIS 2.396 billion. Pumping-energy expense rose to NIS 1.004 billion. Depreciation on water facilities rose to NIS 790 million. Municipal taxes rose to NIS 155 million. What squeezed profitability was a combination of purchased inputs, energy and infrastructure, not one isolated managerial mistake.

On the revenue side, water-sales revenue rose only 3.7% to NIS 4.707 billion. Water charges rose 66.8% to NIS 654 million, but that still did not close the gap. Works revenue slipped slightly to NIS 411 million. The outcome is a system that keeps growing in physical scale, but with much weaker profitability.

The move toward purchased desalinated water changes the quality of the model

In 2024 Mekorot purchased 541.2 mcm of desalinated water. In 2025 that number reached 680.6 mcm. That is a 25.8% jump in one year. The significance is not only operational. It changes the economics of the system: more purchased water, more dependence on tariff recognition, and more sensitivity to whether cost recognition is complete and accurate.

In fact, purchased water from others represented about 42.9% of cost of sales and works in 2025, up from 36.8% in 2024. That means Mekorot's profitability now depends less on extracting value only from its existing asset base and more on its ability to pass through the cost of water it buys from third parties.

Labor cost did not disappear. Part of it moved into the balance sheet

Anyone reading only the income statement could conclude that labor is not the main pressure point because wage expense in cost of sales and overhead looks relatively stable. That is only a partial read. Total salaries, wages and related expenses reached NIS 807 million in 2025 versus NIS 736 million in 2024, and NIS 198 million of that was capitalized into water-facility investments, up from NIS 141 million in 2024.

In other words, part of the cost pressure is not hitting only profit and loss. It is also moving into the development plan and the balance sheet. That matters especially in a company that lives on continuous, debt-funded development.

The employee table sharpens the point. Average headcount was unchanged at 1,535, but total employer cost rose to NIS 604.4 million from NIS 573.5 million. So this is not a story of aggressive hiring. It is mainly a story of a more expensive existing workforce.

Competition is limited, but economic pressure is not

Mekorot operates in a business that is only partly competitive. It produces about 48% of all water produced, treated and desalinated in Israel, and transports and supplies about 65% of total water supply, including volumes to Jordan and the Palestinian Authority. No single customer accounts for 10% of revenue. That is a very real operating moat.

But it is not a free economic moat. In Mekorot's case, monopoly status does not eliminate the profitability test. It only transfers it to the regulator. When price and return are set through regulation, competition is replaced by a different question: does the recognized model still track the actual cost structure that has changed.

Cash flow, debt and capital structure

Two cash bridges matter, and they tell different stories

This is where the analysis has to separate two frameworks. On a normalized cash-generation basis, the company still produced NIS 954 million of operating cash flow. That is lower than last year, but it does not describe an entity that suddenly stopped generating cash.

But once the analysis shifts to all-in cash flexibility, the picture becomes much less comfortable. In 2025 Mekorot had NIS 954 million of cash flow from operations, against NIS 1.827 billion of investment in property, plant and equipment, NIS 860 million of bond principal repayments, NIS 418 million of interest paid and NIS 33 million of lease principal repayments. On the basis of actual cash uses, before new financing, the gap reached about NIS 2.184 billion. Even after the new bond issue, the balance was still negative by about NIS 684 million.

That does not mean the company cannot live with this structure. It does mean its funding flexibility relies on continued debt-market access and on the ability to keep rolling development spending into a regulatory model that eventually recognizes it.

The balance sheet is still standing, but leverage is getting heavier

Bonds rose to NIS 14.339 billion on the balance sheet, versus NIS 13.460 billion in 2024. At the same time, equity fell to NIS 5.809 billion. The bond-to-equity ratio rose from about 2.06 to about 2.47. Net of cash and short-term investments, net bond debt rose to about NIS 12.731 billion.

The liquidity layer also narrowed. Short-term investments fell from NIS 949 million to NIS 358 million, while cash stayed around NIS 1.25 billion. The current ratio fell from roughly 1.26 to roughly 1.00, and the company itself says the working-capital surplus, excluding regulatory deferred balances, shrank to only NIS 5 million.

The debt itself is still long dated. Series 11 runs to 2053, and scheduled maturities over the next five years range between NIS 635 million and NIS 890 million per year, before NIS 10.651 billion in year six and beyond. So this is not a near-term maturity wall. The real issue is whether shrinking equity and a continuing development burden remain compatible with the regulatory model.

Regulatory assets are an accounting cushion, not free cash

One of the most important numbers in the report, and maybe also one of the easiest to miss, is the jump in the net regulatory asset to NIS 1.257 billion from NIS 436 million in 2024. Regulatory assets on the asset side rose to NIS 1.719 billion, while regulatory liabilities fell to NIS 462 million.

That explains why the net loss before changes in regulatory deferred balances was NIS 1.371 billion, but after those balances the reported loss was "only" NIS 741 million. The question readers need to ask is not whether the accounting treatment is allowed. It is. The real question is what it means economically. And the answer is that part of the pain has been deferred into future tariff recognition, not removed.

Another important signal sits in collections. Mekorot says that as of the report date, charges generated through the end of December 2025 totaling about NIS 292 million had not yet been collected, and in early 2026 additional charges related to 2025 and prior years totaling about NIS 336 million were issued. So even when the economic right exists, the cash does not always arrive on the same timetable.

Outlook

The most important part of the 2025 report is not only what happened, but what part of it may continue into 2026. Before getting into the broader discussion, it is worth isolating five non-obvious findings:

First: the NIS 1.367 billion impairment is not the whole story. Even before it, gross profit had already fallen to just NIS 188 million, so the core business had already signaled a real economic problem.

Second: the final reported line is softened by NIS 630 million of positive movement in regulatory deferred balances. That is not cash coming in. It is recognition pushed into the future through the tariff structure.

Third: the impairment model itself assumes two scenarios for returning to full operating-cost coverage, but the company simultaneously stresses that the test does not include future development costs, even though the Water Authority approved annual development of about NIS 1.6 billion. If development continues under the same framework, the hit may not be a one-off event.

Fourth: even inside the cost base, the growing burden is a water system that buys more desalinated water from third parties. That is a structural shift in Mekorot's economics, not just a one-year fluctuation.

Fifth: Mekorot still has a very deep operating moat, but it also carries operational-regulatory friction that does not get enough attention. Only about 39% of items requiring a business license hold a valid license, and less than half of the company's facilities have statutory approvals. In a legacy infrastructure company with a very large asset base that is not shocking, but it does add real execution friction to an aggressive development plan.

2026 looks like a bridge year, not a clean reset

The right way to frame 2026 is as a bridge year. It is not a collapse year, because the operating system keeps working, debt funding has not been shut off, and water demand does not behave like a normal business cycle. But it is not a quick clean-up year either, because the dispute over the new rules is still unresolved, and a follow-up discussion at the Water Authority was supposed to take place by the end of the third quarter of 2026.

That reading is reinforced by the language on both sides. The Water Authority argues that the new rules improve recognition and should lead to higher tariff recognition. Mekorot says almost the opposite, warning about pressure on the rating, financing costs and the ability to deliver the full development plan. In that kind of setup, 2026 is not a year of clarity. It is a proof year.

What has to happen by the end of the third quarter of 2026

First, the regulatory discussion cannot remain cosmetic. If the rules stay in place without enough adjustment, the company itself says that continued execution of the development plan could generate additional losses in future years.

Second, development has to continue without widening the gap. Mekorot is in the middle of several heavy programs, including the fifth system to Jerusalem, Western Galilee infrastructure, the Arava program, eastern valleys connection, reinforcement of water supply in Judea and Samaria, and the Yarkon redemption project. Even without listing every number in a table, the report makes clear that this is a multi-year, multi-billion-shekel execution commitment.

Third, the funding-coverage test has to move from normative language into something lenders will actually respect. The company repeatedly notes that the earlier government target called for FFO-to-debt of 9% in 2026 and 10% in 2030, while the new rules refer to 8% on a normative basis. This is not a semantic debate. It is a debate over what actually counts as resilience.

Fourth, electricity and input-cost relief has to start showing up in practice. Otherwise, even if the regulatory discussion moves in a better direction, energy expense and purchased desalinated-water costs will keep eating the margin.

What the debt market is likely to watch next

Because this is a bond issuer rather than an equity story, the relevant near-term market is the credit market. It will likely focus on three things. First, whether the dispute with the Water Authority moves toward something that stabilizes equity and coverage. Second, whether future debt issuance will still be priced in an environment that assumes regulatory and sovereign support. Third, whether the gap between regulatory recognition and actual costs narrows, or keeps being pushed into deferred balances.

Risks

The main risk is regulatory, but its impact is financial

Mekorot's main risk today is not weakening demand. It is the possibility that the company has to execute a national development plan under rules that do not provide an adequate return or full cost coverage. That is a regulatory risk whose direct translation is financial: equity shrinks, leverage rises, and funding costs could move higher.

The development plan itself can become a risk multiplier

Mekorot explicitly says the impairment test does not include future development costs, even though the Water Authority approved annual development of about NIS 1.6 billion. That is a critical point. If the company keeps investing at those levels under the same framework, the hit to earnings may not remain behind it.

Licensing, statutory approvals and protection zones are real operating friction

The report says only about 39% of items requiring business licenses have a valid license, that less than half of the facilities have statutory approvals, and that protection zones around wells can make it harder to develop new or replacement wells. This is not an immediate cash-flow shock, but for a company that must keep expanding national infrastructure it becomes an execution constraint over time.

Collections and working capital

Another risk, less visible but important, is the time gap between billing and collection. The unpaid Amendment 27 charges and the sharp collapse in the working-capital surplus show that Mekorot does not operate only against a theoretical tariff. It also operates against the pace of collection, disputes and settlements that pull cash out of the present and into the future.

The war did not create a material disruption, but it did raise the required operating threshold

The company says there was no material harm to cash flow and water supply continuity, but it also bought emergency equipment, increased inventories, hardened facilities and worked on business continuity. So even without a material operating disruption, the security environment raises the cost base and the level of operational complexity.

Conclusions

Mekorot ends 2025 as a company whose operating system is still strong, essential and resilient, but whose capital layer and economic model have entered a new test. What still supports the thesis is hard demand, the ability to keep the system running even through war, and the fact that debt-market access has not been shut. The main blocker is that the new regulatory framework has already cut the equity base while the national development burden still has to continue. Over the short to medium term, the decisive question is not whether Mekorot is important to the country. It is whether the model meant to fund it still holds.

Current thesis in one line: Mekorot remains a strong water system, but the model above it no longer provides a clean margin of safety.

What changed from the earlier understanding: in 2025 this is no longer only a story of timing gaps and the assumption that future tariffs will close everything. The issue has moved into the equity layer, the recognized rate of return and the question of whether continued development creates value or weighs on the company.

The strongest counter-thesis: the Water Authority argues that the new rules actually improve tariff recognition, support an FFO-to-debt ratio of at least 8%, allow broader operating flexibility, and that much of the write-down reflects Mekorot's conservative accounting interpretation more than a true cash-flow deterioration.

What could change the market's interpretation over the short to medium term: a practical revision of the rules or a regulatory discussion that narrows the gap, continued access to debt without a sharp jump in pricing, and visible relief from electricity and development costs.

Why this matters: if Mekorot cannot reconcile its national role with an economic framework that can fund it, the implication is not just one weak report. It is a national infrastructure model entering sustained friction.

What has to happen over the next 2 to 4 quarters for the thesis to strengthen: the company needs better regulatory clarity, proof that continued development will not create another round of impairments, and relatively comfortable debt-market access. What would weaken the thesis is continued development under unresolved rules, further erosion in equity, or a first sign of pressure on the rating and the cost of funding.

---